Page 79 - Chief Development News Today

Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and...

IRVINE, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic

Protalix Biotherapeutics and Chiesi Global Rare Diseases Provide Regulatory Update on PRX-102 for the Treatment of Fabry Disease - read this article along with other careers information, tips and advice on BioSpace

Sarasota, FL (PRWEB) October 07, 2021 -- Dental Care Alliance (DCA) announces the addition of Dental Care of Alexandria and McLean to its growing family of

Health, SARASOTA Fla. (PRWEB) October 07 2021 Dental Care Alliance (DCA) announces the addition of Dental Care of Alexandria and McLean to its growing family of allied pract,Dental,Care,Alliance,welcomes,Dental,Care,of,Alexandria,and,McLean,to,its,growing,family,of,allied,practices,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news

/PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its...

Qatari Diar has signed a contract with ELAN Media Company for the development of outdoor advertising spaces in  Lusail, Qatar’s city of the future.

Qatari Diar has signed a contract with ELAN Media Company for the development of outdoor advertising spaces in  Lusail, Qatar’s city of the future.

Clearside Biomedical, Inc. , a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that multiple presentations were given at the Retina Society 54 th Annual Scientific Meeting which took place September 29 October 2, 2021 in Chicago, IL. “These presentations demonstrate the targeted and ...